We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
-15.11%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$96.6M
AUM Growth
-$25.4M
(-21%)
Cap. Flow
+$324K
Cap. Flow
% of AUM
0.34%
Top 10 Holdings %
Top 10 Hldgs %
32.65%
Holding
115
New
5
Increased
35
Reduced
28
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ABTC
American Bitcoin Corp
ABTC
|
+$1.24M |
| 2 |
Magnite
MGNI
|
+$1.21M |
| 3 |
Fortress Biotech
FBIO
|
+$650K |
| 4 |
NeoGenomics
NEO
|
+$477K |
| 5 |
SRXH
SRX Global
SRXH
|
+$412K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATRS
Antares Pharma, Inc.
ATRS
|
+$1.97M |
| 2 |
LeMaitre Vascular
LMAT
|
+$1.95M |
| 3 |
International Flavors & Fragrances
IFF
|
+$563K |
| 4 |
AT&T
T
|
+$223K |
| 5 |
Costco
COST
|
+$219K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 54.22% |
| 2 | Technology | 19.39% |
| 3 | Communication Services | 8.2% |
| 4 | Consumer Staples | 7.55% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NEUE
101
DELISTED
NeueHealth
NEUE
| $18K | 0.02% |
+125
| New | +$18.2K |
|
|
CTEK
102
DELISTED
CynergisTek, Inc.
CTEK
| $18K | 0.02% |
15,000
-90,000
| -86% | -$92.1K |
|
|
ATHX
103
DELISTED
Athersys, Inc. Common Stock
ATHX
| $18K | 0.02% |
2,720
-160
| -6% | -$1.77K |
|
104
Air Industries Group
AIRI
$13.1M
| $11K | 0.01% |
1,600
| – | – |
|
|
TONX
105
TON Strategy Co
TONX
$177M
| $6K | 0.01% |
2
| – | – |
|
106
Bluejay Diagnostics
BJDX
$983K
| – | – |
-1
| Closed | -$25K |
|
|
107
Costco
COST
$422B
| – | – |
-380
| Closed | -$219K |
|
108
Quest Diagnostics
DGX
$25.6B
| – | – |
-1,475
| Closed | -$202K |
|
|
109
International Flavors & Fragrances
IFF
$20.5B
| – | – |
-4,285
| Closed | -$563K |
|
110
Inogen
INGN
$183M
| – | – |
-6,700
| Closed | -$217K |
|
111
Standard BioTools
LAB
$340M
| – | – |
-19,600
| Closed | -$70K |
|
|
112
LeMaitre Vascular
LMAT
$2.37B
| – | – |
-42,000
| Closed | -$1.95M |
|
113
Viatris
VTRS
$20.4B
| – | – |
-10,546
| Closed | -$115K |
|
|
ATRS
114
DELISTED
Antares Pharma, Inc.
ATRS
| – | – |
-481,483
| Closed | -$1.97M |
|
Similar funds
SVP
PWP
BF
SFG
HWMG
FTEA
WT
BAM
Perkins Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Perkins Capital Management held 115 positions worth $96.6M, down 21% from $122M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Perkins Capital Management's Q2 2022 filing shows 5 new, 35 increased, 28 reduced and 10 closed positions. Its largest new stake was American Bitcoin Corp: 72 shares worth $300K. The largest sale was Antares Pharma, Inc., an estimated $1.97M.
By sector, the portfolio is most concentrated in Healthcare at 54% of assets, down from 56% a quarter earlier, followed by Technology and Communication Services.
- Perkins Capital Management's largest Q2 2022 buy was American Bitcoin Corp: 72 shares worth $300K.
- Perkins Capital Management added most to Magnite in Q2 2022, an estimated $1.21M increase.
- Perkins Capital Management's biggest Q2 2022 reduction was AT&T, cutting an estimated $223K.
- Perkins Capital Management fully exited Antares Pharma, Inc. in Q2 2022, selling an estimated $1.97M.
- Perkins Capital Management's ten largest holdings make up 33% of its $96.6M portfolio in Q2 2022.
- Perkins Capital Management opened 5 new positions and closed 10 in Q2 2022.
- Perkins Capital Management's portfolio value fell 21% quarter-over-quarter to $96.6M.
Based on Perkins Capital Management's 13F filing for Q2 2022, filed 29 Jul 2022.